Product details
Catalog number M00555-8
Price for M00555-8
Size / count 100 µg
Boster Bio Anti-PTPRC / CD45 Reference Antibody (Novartis patent anti-CD45) (Catalog # M00555-8) . Tested in Flow Cytometry, ELISA, FTA. This antibody reacts with Human. Endotoxin: < 0.412EU/μg, determined by LAL method. Expression system: CHO Cell
The catalog number for Anti-PTPRC / CD45 Reference Antibody (Novartis patent anti-CD45) is M00555-8.
Anti-PTPRC / CD45 Reference Antibody (Novartis patent anti-CD45) is available in the following size(s): 100 µg.
Anti-PTPRC / CD45 Reference Antibody (Novartis patent anti-CD45) is currently made to order / not held in immediate stock. Contact us for lead time.
The safety data sheet for Anti-PTPRC / CD45 Reference Antibody (Novartis patent anti-CD45) is available here: https://www.bosterbio.com/msds?sku=M00555-8.
Boster Bio Anti-PTPRC / CD45 Reference Antibody (Novartis patent anti-CD45) (Catalog # M00555-8) . Tested in Flow Cytometry, ELISA, FTA. This antibody reacts with Human. Endotoxin: < 0.412EU/μg, determined by LAL method. Expression system: CHO Cell
Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.
A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.
Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.